Business Standard

BPL Medical Tech to scale up global presence, aims to break even in FY19

The acquisition can either be in devices or consumable space, and the company is looking at investing anywhere between Rs 50 crore to Rs 100 crore for this acquisition

BPL medical, pharmaceuticals,
Premium

In the domestic market, BPL has already established itself as a leader in the ECG segment

Bibhu Ranjan Mishra Bengaluru
In all likelihood, FY19 is going to be a milestone year for Goldman Sachs-backed medical device manufacturer BPL Medical Technologies.

The Bengaluru-based company, in which the Nambiar family still holds around 35 per cent stake, is expecting to break even this year. 

The firm is also zeroing in on another global acquisition as it targets to cross Rs 1,000 crore in revenue by 2022, managing director and chief executive officer Sunil Khurana told Business Standard.

Khurana, a veteran in the healthcare space who had spent almost 28 years in GE Healthcare, joined BPL Medical Technologies in August 2013 immediately after

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in